MorphoSys To Present At the 39th Annual J.P. Morgan Healthcare Conference
The Pharma Data
JANUARY 10, 2021
For more information, please contact: SOURCE: MorphoSys AG via EQS Newswire. View source version on accesswire.com: [link].
The Pharma Data
JANUARY 10, 2021
For more information, please contact: SOURCE: MorphoSys AG via EQS Newswire. View source version on accesswire.com: [link].
The Pharma Data
JANUARY 24, 2021
In clinical research, Cepharanthine exhibits multiple pharmacological properties including anti-oxidative, anti-inflammatory, immuno-regulatory, anti-cancer, anti-viral and anti-parasitic properties. Sairiyo is currently focused on advancing the clinical development of Cepharanthine to treat rare cancer diseases. PharmaDrug Inc.
Let's personalize your content